Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
186.80    0.20 (0.11%)
Bid:
186.40
Ask:
186.60
Spread: 0.20 (0.107%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Trading Statement

28 Jul 2020 07:00

RNS Number : 2196U
B&M European Value Retail S.A.
28 July 2020
 

 

 

 

28 July 2020

B&M European Value Retail S.A.

 

Trading Update

 

 

B&M European Value Retail S.A., ("the Group") the UK's leading general merchandise value retailer, today provides a trading update relating to its Year To Date performance.

 

On 1 July 2020, the Group announced that it had made a strong start to the new financial year and, against a highly uncertain economic backdrop and continued impacts from Covid19, B&M was well placed to continue to grow profitably in the UK and continue to develop and prove the proposition in France.

 

The Group's current expectation for the six months to 26 September 2020 ("H1 FY21") Adjusted EBITDA1 (on a pre-IFRS 16 basis) is that it is likely to be in the range of £250m to £270m. The average analysts' consensus forecast2 for H1 FY21 Adjusted EBITDA1 (on a pre-IFRS 16 basis) is £208.1m.

 

There remains considerable uncertainty in relation to both the progression of Covid-19 and the economic outlook and it is therefore hard to predict trading levels for the second half of the year.

 

The safety of the Group's colleagues and customers remains the key priority whilst working hard to continue to meet customers' needs in these difficult times. A more detailed update at the Half Year Results announcement is scheduled for 12 November 2020.

 

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation.

 

1. The Directors consider adjusted EBITDA figures to be more reflective of the underlying business performance of the Group and believe that this measure provides additional useful information for investors on the Group's performance. Adjusting items are the effects of derivatives, one off refinancing fees, foreign exchange on the translation of intercompany balances and the effects of revaluing or unwinding balances related to the acquisition of subsidiaries.

 

2. The consensus estimate for Adjusted EBITDA is based upon the average of 9 analyst publications that provide H1 FY21 estimates.

 

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400 ext 5766

Simon Arora, Chief Executive

Paul McDonald, Chief Financial Officer

Steve Webb, Investor Relations Director

Investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Maitland, Daniel Yea

bmstores-maitland@maitland.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEAKXXADEEEFA
Date   Source Headline
16th Jul 20218:00 amRNSDirector/PDMR Shareholding
14th Jul 202111:22 amRNSDirector/PDMR Shareholding
13th Jul 20219:00 amRNSBlock listing Interim Review
8th Jul 20217:00 amRNSTrading Statement
21st Jun 20217:00 amRNSAnnual Financial Report
3rd Jun 20217:00 amRNSBoard Change
3rd Jun 20217:00 amRNSPreliminary Results
15th Mar 202110:16 amRNSHolding(s) in Company
4th Mar 20217:00 amRNSTrading Update
1st Mar 20219:48 amRNSTotal Voting Rights
25th Feb 20219:20 amRNSDirector Declaration
22nd Feb 20215:06 pmRNSDirector/PDMR Securities
10th Feb 20212:16 pmRNSHolding(s) in Company
9th Feb 202110:05 amRNSHolding(s) in Company
27th Jan 20217:00 amRNSHolding(s) in Company
20th Jan 20213:17 pmRNSHolding(s) in Company
20th Jan 202111:02 amRNSHolding(s) in Company
15th Jan 20214:02 pmRNSHolding(s) in Company
14th Jan 202112:52 pmRNSDirector/PDMR Shareholding
13th Jan 20219:24 amRNSBlock listing Interim Review
12th Jan 202110:00 amRNSDirector Declaration
12th Jan 20217:00 amRNSResults of Placing
11th Jan 20215:22 pmRNSProposed Secondary Placing
7th Jan 20217:00 amRNSTrading Statement
29th Dec 20209:25 amRNSDirector/PDMR Securities
29th Dec 20209:18 amRNSDirector/PDMR Securities
4th Dec 20207:00 amRNSResult of EGM
3rd Dec 20204:20 pmRNSTrading Update
17th Nov 202012:39 pmRNSDirector/PDMR Shareholding
16th Nov 202011:12 amRNSDirector/PDMR Shareholding
13th Nov 202012:35 pmRNSDirector/PDMR Shareholding
12th Nov 20207:00 amRNSHalf-year Report
28th Oct 20207:00 amRNSNotice of EGM
30th Sep 20209:36 amRNSTotal Voting Rights
29th Sep 20207:00 amRNSTrading Update
21st Sep 20209:53 amRNSResult of AGM
1st Sep 20209:40 amRNSTotal Voting Rights
30th Jul 202011:20 amRNSDirector/PDMR Shareholding
28th Jul 20207:00 amRNSTrading Statement
20th Jul 20209:00 amRNSPost Stabilisation Notice
14th Jul 20209:50 amRNSDirector/PDMR Shareholding
13th Jul 20209:09 amRNSBlock listing Interim Review
9th Jul 20202:28 pmRNSBoard Changes
7th Jul 20204:05 pmRNSHolding(s) in Company
7th Jul 20209:01 amRNSHolding(s) in Company
2nd Jul 20206:19 pmRNSPricing of Senior Secured Notes Offering
1st Jul 202011:07 amRNSPre Stabilisation Notice
1st Jul 20209:02 amRNSLaunch of Senior Secured Notes Offering
1st Jul 20207:00 amRNSTrading Statement
1st Jul 20207:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.